213 related articles for article (PubMed ID: 21537957)
1. Molecular dynamics simulation and density functional theory studies on the active pocket for the binding of paclitaxel to tubulin.
Xu S; Chi S; Jin Y; Shi Q; Ge M; Wang S; Zhang X
J Mol Model; 2012 Jan; 18(1):377-91. PubMed ID: 21537957
[TBL] [Abstract][Full Text] [Related]
2. Structural insight into the mechanism of epothilone A bound to beta-tubulin and its mutants at Arg282Gln and Thr274Ile.
Shi G; Wang Y; Jin Y; Chi S; Shi Q; Ge M; Wang S; Zhang X; Xu S
J Biomol Struct Dyn; 2012; 30(5):559-73. PubMed ID: 22731768
[TBL] [Abstract][Full Text] [Related]
3. The key residues of active sites on the catalytic fragment for paclitaxel interacting with poly (ADP-ribose) polymerase.
Wang Y; Bian F; Deng S; Shi Q; Ge M; Wang S; Zhang X; Xu S
J Biomol Struct Dyn; 2011 Jun; 28(6):881-93. PubMed ID: 21469749
[TBL] [Abstract][Full Text] [Related]
4. Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin.
Chi S; Xie W; Zhang J; Xu S
J Biomol Struct Dyn; 2015; 33(10):2234-54. PubMed ID: 25588192
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Binding Interaction Mechanism of Taxol in β-Tubulin and Bovine Serum Albumin: A Biophysical Approach.
Karthikeyan S; Bharanidharan G; Ragavan S; Kandasamy S; Chinnathambi S; Udayakumar K; Mangaiyarkarasi R; Suganya R; Aruna P; Ganesan S
Mol Pharm; 2019 Feb; 16(2):669-681. PubMed ID: 30601011
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel binding to human and murine MD-2.
Zimmer SM; Liu J; Clayton JL; Stephens DS; Snyder JP
J Biol Chem; 2008 Oct; 283(41):27916-27926. PubMed ID: 18650420
[TBL] [Abstract][Full Text] [Related]
7. Structural investigations into the binding mode of novel neolignans Cmp10 and Cmp19 microtubule stabilizers by in silico molecular docking, molecular dynamics, and binding free energy calculations.
Tripathi S; Kumar A; Kumar BS; Negi AS; Sharma A
J Biomol Struct Dyn; 2016 Jun; 34(6):1232-40. PubMed ID: 26212016
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Paclitaxel Resistant R306C Mutation in β-Tubulin—A Computational Approach.
Verma K; Ramanathan K
J Cell Biochem; 2015 Jul; 116(7):1318-24. PubMed ID: 25735511
[TBL] [Abstract][Full Text] [Related]
9. The taxol pharmacophore and the T-taxol bridging principle.
Kingston DG; Bane S; Snyder JP
Cell Cycle; 2005 Feb; 4(2):279-89. PubMed ID: 15611640
[TBL] [Abstract][Full Text] [Related]
10. Investigation of structural requirements of anticancer activity at the paclitaxel/tubulin binding site using CoMFA and CoMSIA.
Islam MN; Song Y; Iskander MN
J Mol Graph Model; 2003 Jan; 21(4):263-72. PubMed ID: 12479926
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.
Hari M; Loganzo F; Annable T; Tan X; Musto S; Morilla DB; Nettles JH; Snyder JP; Greenberger LM
Mol Cancer Ther; 2006 Feb; 5(2):270-8. PubMed ID: 16505100
[TBL] [Abstract][Full Text] [Related]
12. The quest for a simple bioactive analog of paclitaxel as a potential anticancer agent.
Kingston DG; Snyder JP
Acc Chem Res; 2014 Aug; 47(8):2682-91. PubMed ID: 25052294
[TBL] [Abstract][Full Text] [Related]
13. The tubulin-bound conformation of paclitaxel: T-taxol vs "PTX-NY".
Yang Y; Alcaraz AA; Snyder JP
J Nat Prod; 2009 Mar; 72(3):422-9. PubMed ID: 19267457
[TBL] [Abstract][Full Text] [Related]
14. Dissecting paclitaxel-microtubule association: quantitative assessment of the 2'-OH group.
Sharma S; Lagisetti C; Poliks B; Coates RM; Kingston DG; Bane S
Biochemistry; 2013 Apr; 52(13):2328-36. PubMed ID: 23473345
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
Tripathi S; Srivastava G; Sharma A
Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604
[TBL] [Abstract][Full Text] [Related]
16. Interaction of a fluorescent paclitaxel analogue with tubulin.
Sengupta S; Boge TC; Georg GI; Himes RH
Biochemistry; 1995 Sep; 34(37):11889-94. PubMed ID: 7547924
[TBL] [Abstract][Full Text] [Related]
17. ClC-3 promotes paclitaxel resistance via modulating tubulins polymerization in ovarian cancer cells.
Feng J; Peng Z; Gao L; Yang X; Sun Z; Hou X; Li E; Zhu L; Yang H
Biomed Pharmacother; 2021 Jun; 138():111407. PubMed ID: 33765585
[TBL] [Abstract][Full Text] [Related]
18. Differential assembly kinetics of alpha-tubulin isoforms in the presence of paclitaxel.
Banerjee A; Kasmala LT
Biochem Biophys Res Commun; 1998 Apr; 245(2):349-51. PubMed ID: 9571153
[TBL] [Abstract][Full Text] [Related]
19. Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.
Sato S; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Iba T; Naniwa J; Uegaki K; Terakawa N
Cancer Chemother Pharmacol; 2004 Mar; 53(3):247-52. PubMed ID: 14610615
[TBL] [Abstract][Full Text] [Related]
20. A molecular docking study of anticancer drug paclitaxel and its analogues.
Sinha R; Vidyarthi AS; Shankaracharya
Indian J Biochem Biophys; 2011 Apr; 48(2):101-5. PubMed ID: 21682141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
